Comorbidity of gout and rheumatoid arthritis in a large population database

Rona Merdler-Rabinowicz1,2, Shmuel Tiosano1,2, Doron Comaneshter3

  • 1Department of Medicine 'B', Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, 52621, Tel Hashomer, Israel.

Clinical Rheumatology
|November 13, 2016
PubMed

Insights

Rheumatoid arthritis patients have a higher prevalence of gout than previously thought. This study found rheumatoid arthritis is significantly associated with gout, challenging the notion of their rare coexistence.

Area of Science:

  • Rheumatology
  • Epidemiology

Background:

  • The coexistence of rheumatoid arthritis and gout is often considered uncommon.
  • Existing literature suggests a low prevalence of gout among rheumatoid arthritis patients.

Purpose of the Study:

  • To investigate the prevalence of gout in patients diagnosed with rheumatoid arthritis.
  • To compare the incidence of gout in rheumatoid arthritis patients versus the general population.

Main Methods:

  • A population-based cross-sectional study was conducted using data from Clalit Health Services.
  • 11,540 rheumatoid arthritis patients were compared with 56,763 age- and sex-matched controls.
  • Data included BMI, socioeconomic status, smoking, hypertension, and gout diagnosis.

Main Results:

  • The prevalence of gout was significantly higher in rheumatoid arthritis patients (1.61%) compared to controls (0.92%).
  • Multivariate analysis revealed a significant association between rheumatoid arthritis and gout (OR = 1.72).
  • The proportion of gout in rheumatoid arthritis patients was not lower than in the general population.

Conclusions:

  • The coexistence of rheumatoid arthritis and gout is more common than previously believed.
  • Rheumatoid arthritis is independently associated with an increased risk of developing gout.
  • Findings suggest a potential shared pathophysiology or increased susceptibility to crystal deposition in rheumatoid arthritis patients.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
878
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
717
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
450
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.6K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
575